Q32 Bio, Inc. (QTTB)
11.07
-0.03
(-0.27%)
USD |
NASDAQ |
Sep 14, 11:13
Q32 Bio Price to Book Value : 2.481 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.488 |
| September 10, 2026 | 2.403 |
| September 09, 2026 | 2.497 |
| September 08, 2026 | 2.620 |
| September 04, 2026 | 2.687 |
| September 03, 2026 | 2.869 |
| September 02, 2026 | 3.046 |
| September 01, 2026 | 3.218 |
| August 31, 2026 | 3.333 |
| August 28, 2026 | 3.369 |
| August 27, 2026 | 3.620 |
| August 26, 2026 | 3.626 |
| August 25, 2026 | 3.658 |
| August 24, 2026 | 3.667 |
| August 21, 2026 | 3.579 |
| August 20, 2026 | 3.555 |
| August 19, 2026 | 3.550 |
| August 18, 2026 | 3.427 |
| August 17, 2026 | 3.575 |
| August 14, 2026 | 3.396 |
| August 13, 2026 | 3.445 |
| August 12, 2026 | 3.445 |
| August 11, 2026 | 3.454 |
| August 10, 2026 | 3.512 |
| August 07, 2026 | 3.496 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.631 |
| August 05, 2026 | 3.696 |
| August 04, 2026 | 3.621 |
| August 03, 2026 | 3.399 |
| July 31, 2026 | 3.514 |
| July 30, 2026 | 3.488 |
| July 29, 2026 | 3.281 |
| July 28, 2026 | 3.521 |
| July 27, 2026 | 3.409 |
| July 24, 2026 | 3.396 |
| July 23, 2026 | 3.447 |
| July 22, 2026 | 3.380 |
| July 21, 2026 | 3.454 |
| July 20, 2026 | 3.371 |
| July 17, 2026 | 3.373 |
| July 16, 2026 | 3.409 |
| July 15, 2026 | 3.519 |
| July 14, 2026 | 4.138 |
| July 13, 2026 | 4.792 |
| July 10, 2026 | 2.512 |
| July 09, 2026 | 2.822 |
| July 08, 2026 | 3.156 |
| July 07, 2026 | 3.053 |
| July 06, 2026 | 2.883 |
| July 02, 2026 | 2.934 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.370 |
| Prelude Therapeutics, Inc. | 2.773 |
| Intellia Therapeutics, Inc. | 2.288 |
| Twist Bioscience Corp. | 17.97 |
| Revolution Medicines, Inc. | 16.49 |
Price to Book Value Related Metrics
| PE Ratio | 3.688 |
| PS Ratio | 3.053 |
| Price | 11.07 |
| Earnings Yield | 27.11% |
| Market Cap | 262.76M |
| Operating PE Ratio | 7.643 |
| Normalized PE Ratio | 3.682 |